Skip to main content
logo
OncoTherapy Science, Inc. (TYO:4564)
Japan flag Japan · Delayed Price · Currency is JPY
22.00
-1.00 (-4.35%)
Sep 16, 2026, 3:30 PM JST

OncoTherapy Science Ratios and Metrics

Millions JPY. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
9,3908,0577,6064,3539,05413,292
Market Cap Growth
18.54%5.92%74.74%-51.92%-31.88%-38.71%
Enterprise Value
7,0645,8726,6613,7558,07711,071
Last Close Price
23.0021.0028.0020.0047.0069.00

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Forward PE
-25.4925.4925.4925.4925.49
PS Ratio
12.089.9710.147.147.9811.53
PB Ratio
4.003.7610.4512.3310.606.72
P/TBV Ratio
4.003.7610.4512.3310.606.72
PEG Ratio
-0.760.760.760.760.76

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
9.097.278.886.167.129.60

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Debt / Equity Ratio
-0.99-0.98-1.14-1.49-1.31-0.93
Net Debt / EBITDA Ratio
----1.020.90
Net Debt / FCF Ratio
-2.121.020.431.400.73
Asset Turnover
0.380.460.740.510.540.38
Inventory Turnover
12.4518.9916.6017.0410.9720.37
Quick Ratio
11.0912.972.851.992.043.70
Current Ratio
11.8113.663.382.282.344.31
Return on Equity (ROE)
-51.56%-63.44%-150.79%-213.42%-78.93%-101.74%
Return on Assets (ROA)
-23.87%-28.81%-49.27%-58.87%-32.98%-42.40%
Return on Capital Employed (ROCE)
-33.00%-37.00%-96.30%-220.50%-122.70%-98.70%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-9.41%-11.29%-10.71%-29.59%-12.35%-19.34%
FCF Yield
-10.48%-12.21%-10.71%-28.23%-8.81%-19.03%
Buyback Yield / Dilution
-31.59%-25.69%-22.73%-10.45%-2.76%-6.31%